Phase II investigator-initiated study of brentuximab vedotin in mycosis fungoides and Sézary syndrome with variable CD30 expression level: A multi-institution collaborative project

Youn H. Kim, Mahkam Tavallaee, Uma Sundram, Katrin A. Salva, Gary S. Wood, Shufeng Li, Sima Rozati, Seema Nagpal, Michael Krathen, Sunil Reddy, Richard T. Hoppe, Annie Nguyen-Lin, Wen Kai Weng, Randall Armstrong, Melissa Pulitzer, Ranjana H. Advani, Steven M. Horwitz

Research output: Contribution to journalArticlepeer-review

209 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II investigator-initiated study of brentuximab vedotin in mycosis fungoides and Sézary syndrome with variable CD30 expression level: A multi-institution collaborative project'. Together they form a unique fingerprint.

Medicine & Life Sciences